Icure Pharmaceutical Inc. is a privately held specialty drugs company with its office and research laboratory located in Sungnam City and KGMP approved manufacturing facility located at Anseong City in Korea. Icure's business strategy is to develop innovative transdermal drug delivery systems for local systemic and device aided delivery of drugs. Icure is developing the transdermal formulations that enhance therapeutic value of the drugs by reducing side effects, enhancing efficacy and promoting patient compliance.

The company has successfully developed and commercialized several pharmaceutical plasters and patches for the treatment rheumatic arthritis pain and nicotine replacement therapy. These products have been licensed to several leading Korean Pharmaceutical firms for sales in Korea.

The future products pipeline is aimed at the development for diseases such as asthma, urinary incontinence and diseases of central nervous system.